SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058070
Filing Date
2021-11-10
Accepted
2021-11-10 14:32:41
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_aikidopharma.htm   iXBRL 10-Q 588967
2 CERTIFICATION f10q0921ex31i_aikido.htm EX-31.1 12828
3 CERTIFICATION f10q0921ex32i_aikido.htm EX-32.1 5782
  Complete submission text file 0001213900-21-058070.txt   3754749

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20210930.xsd EX-101.SCH 49519
5 XBRL CALCULATION FILE aiki-20210930_cal.xml EX-101.CAL 27275
6 XBRL DEFINITION FILE aiki-20210930_def.xml EX-101.DEF 187036
7 XBRL LABEL FILE aiki-20210930_lab.xml EX-101.LAB 379432
8 XBRL PRESENTATION FILE aiki-20210930_pre.xml EX-101.PRE 200853
9 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_aikidopharma_htm.xml XML 525576
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 211396027
SIC: 8731 Services-Commercial Physical & Biological Research